Polypharmacy, biosimilars, and GLP-1s among the evolving trends likely to play out in the pharmacy benefits space.

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Yes, weight-loss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s ...

Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with ...

In simple terms, walking tires the body and increases the naturally increasing pressure to sleep throughout the day. Res ...

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS candidate RFK Jr told senators the GLP-1s are ‘miracle drugs’ but shouldn’t ...

When used responsibly botulinum toxin is very safe, but patients should be especially vigilant about cosmetic treatments done ...